MEDIGENE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.44 EUR | -4.32% |
|
-25.00% | -5.57% |
Chart calendar Medigene AG
bdafbe82ac8f8d91488b7f.VaiKqtXOkQadopHHJf7p2wnbxKB-sBB2pjKgSrMxYvM.Bp_Anb395mzVwPiiYrS5kk6rt8078lYe1GjzHsFaA5Q_mM2duJ_OM9Lz_g~9d298c5f07c5afa3b877cb097778fc34
Upcoming events on Medigene AG
Past events on Medigene AG
| 26/04/2024 08:00 | Q1 2024 Earnings Release |
| 25/04/2024 13:15 | Europe CHI Immuno- Oncology Summit |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting |
| 28/03/2024 14:00 | Q4 2023 Earnings Call |
| 28/03/2024 06:30 | Q4 2023 Earnings Release |
| 25/03/2024 | H.C. Wainwright Cell Therapy Virtual Conference |
| 07/03/2024 19:10 | ELRIG Forum |
| 04/03/2024 | East-West Biopharma Summit |
| 28/02/2024 17:30 | CAR-TCR Europe Summit |
| 28/02/2024 12:30 | CAR-TCR Europe Summit - Panel |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 27/11/2023 13:05 | Deutsches Eigenkapital Forum |
| 05/11/2023 | Bio-Europe Conference |
| 04/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract number: 388 |
| 26/10/2023 07:30 | Q3 2023 Earnings Release |
| 21/10/2023 11:00 | European Society for Medical Oncology Congress - Presentation Number: 2249P |
| 18/09/2023 13:10 | Baader Investment Conference |
| 11/09/2023 21:30 | H.C. Wainwright Global Investment Conference |
| 30/08/2023 22:00 | CAR TCR Summit |
| 17/08/2023 14:00 | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 10,6 7,95 33.74% | 8,75 8,43 3.85% | 10,5 9,40 11.31% | 0,00 | 6,03 5,50 9.71% | 10,6 |
|
EBITDA Million EUR | Released Forecast Spread | -17,8 -24,0 25.88% | -22,2 -22,0 -0.93% | -6,56 -11,7 43.96% | 0,00 | -14,7 -18,1 18.86% | -11,8 |
|
EBIT Million EUR | Released Forecast Spread | -20,2 -27,0 25.33% | -28,7 -23,3 -22.93% | -9,99 -11,7 14.73% | 0,00 | -16,1 -18,8 13.87% | -11,8 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -19,9 -26,3 24.27% | -28,4 -24,6 -15.63% | -10,3 -14,0 26.55% | 0,00 | -16,6 -19,4 14.25% | -11,7 |
|
Net income Million EUR | Released Forecast Spread | -20,0 -26,3 24.1% | -28,9 -22,8 -26.48% | -9,98 -14,0 28.69% | -8,33 | -16,2 -18,9 14.18% | -11,7 |
|
EPS EUR | Released Forecast Spread | -0,81 -1,09 25.69% | -1,18 -0,93 -27.57% | -0,41 -0,48 14.58% | -0,34 | -0,66 -0,79 16.46% | -0,37 |
| Announcement Date | 26/03/20 | 25/03/21 | 23/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,55 0,00 - | 3,06 0,00 - | 2,97 2,74 8.39% | 4,15 | 6,85 |
|
EBITDA Million EUR | Released Forecast Spread | -6,48 | -6,62 -12,7 47.8% | -8,07 -11,4 29.25% | -7,20 | -4,60 |
|
EBIT Million EUR | Released Forecast Spread | -4,12 | -7,37 | -8,78 -11,4 23.01% | -7,20 | -4,60 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,26 -6,02 29.34% | -7,70 -11,6 33.55% | -8,89 -11,7 23.99% | -7,10 | -4,50 |
|
Net income Million EUR | Released Forecast Spread | -4,06 -6,02 32.61% | -6,97 -11,6 39.85% | -9,21 -12,5 26.34% | -7,10 | -4,50 |
|
EPS EUR | Released Forecast Spread | -0,17 -0,74 77% | -0,28 -1,44 80.58% | -0,38 -0,51 25.49% | -0,28 | -0,12 |
| Announcement Date | 17/08/23 | 17/08/23 | 28/03/24 | - | - |
More events
Past sector events for Medigene AG
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MDG1 Stock
- Calendar Medigene AG
